Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Jay T Backstrom"'
Autor:
Maria Domenica Cappellini, Ali T. Taher, Antonio Piga, Farrukh Shah, Ersi Voskaridou, Vip Viprakasit, John B. Porter, Olivier Hermine, Ellis J. Neufeld, Alexis A. Thompson, Derek Tang, Aylin Yucel, Jennifer Lord‐Bessen, Peiwen Yu, Shien Guo, Jeevan K. Shetty, Dimana Miteva, Tatiana Zinger, Jay T. Backstrom, Esther Natalie Oliva
Publikováno v:
European Journal of Haematology.
Autor:
Esther Natalie Oliva, Uwe Platzbecker, Guillermo Garcia-Manero, Ghulam J. Mufti, Valeria Santini, Mikkael A. Sekeres, Rami S. Komrokji, Jeevan K. Shetty, Derek Tang, Shien Guo, Weiqin Liao, George Zhang, Xianwei Ha, Rodrigo Ito, Jennifer Lord-Bessen, Jay T. Backstrom, Pierre Fenaux
Publikováno v:
Journal of Clinical Medicine, Vol 11, Iss 27, p 27 (2022)
Journal of Clinical Medicine; Volume 11; Issue 1; Pages: 27
Journal of Clinical Medicine
Journal of Clinical Medicine; Volume 11; Issue 1; Pages: 27
Journal of Clinical Medicine
Patients with myelodysplastic syndromes (MDS) often experience chronic anemia and long-term red blood cell transfusion dependence associated with significant burden on clinical and health-related quality of life (HRQoL) outcomes. In the MEDALIST tria
Autor:
Amer M. Zeidan, Uwe Platzbecker, Guillermo Garcia-Manero, Mikkael A. Sekeres, Pierre Fenaux, Amy E. DeZern, Peter L. Greenberg, Michael R. Savona, Joseph G. Jurcic, Amit K. Verma, Ghulam J. Mufti, Rena Buckstein, Valeria Santini, Jeevan K. Shetty, Rodrigo Ito, Jennie Zhang, George Zhang, Xianwei Ha, Jay T. Backstrom, Rami S. Komrokji
Publikováno v:
Blood. 140(20)
Luspatercept is an approved therapy for selected patients with lower risk myelodysplasia requiring transfusion despite erythropoiesis-stimulating agents, based on the early results of a randomized trial against placebo. Zeidan and colleagues report t
Autor:
Rami S. Komrokji, Uwe Platzbecker, Pierre Fenaux, Amer M. Zeidan, Guillermo Garcia-Manero, Ghulam J. Mufti, Valeria Santini, María Díez-Campelo, Carlo Finelli, Joseph G. Jurcic, Peter L. Greenberg, Mikkael A. Sekeres, Amy E. DeZern, Michael R. Savona, Jeevan K. Shetty, Rodrigo Ito, George Zhang, Xianwei Ha, Jay T. Backstrom, Amit Verma
Publikováno v:
Komrokji, R S, Platzbecker, U, Fenaux, P, Zeidan, A M, Garcia-Manero, G, Mufti, G J, Santini, V, Díez-Campelo, M, Finelli, C, Jurcic, J G, Greenberg, P L, Sekeres, M A, DeZern, A E, Savona, M R, Shetty, J K, Ito, R, Zhang, G, Ha, X, Backstrom, J T & Verma, A 2022, ' Luspatercept for myelodysplastic syndromes/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis ', Leukemia, vol. 36, no. 5, pp. 1432-1435 . https://doi.org/10.1038/s41375-022-01521-4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5795a79a697b7c066852afcc82b9358
https://kclpure.kcl.ac.uk/en/publications/d874f6b5-6ac6-47e3-ad43-7c9e445834a6
https://kclpure.kcl.ac.uk/en/publications/d874f6b5-6ac6-47e3-ad43-7c9e445834a6
Autor:
Ali T Taher, Maria Domenica Cappellini, Antonis Kattamis, Ersi Voskaridou, Silverio Perrotta, Antonio G Piga, Aldo Filosa, John B Porter, Thomas D Coates, Gian Luca Forni, Alexis A Thompson, Immacolata Tartaglione, Khaled M Musallam, Jay T Backstrom, Oriana Esposito, Ana Carolina Giuseppi, Wen-Ling Kuo, Dimana Miteva, Jennifer Lord-Bessen, Aylin Yucel, Tatiana Zinger, Jeevan K Shetty, Vip Viprakasit, Jassada Buaboonnam, Supachai Ekwattanakit, Archrob Khunhapinant, Efthalia Loka, Maria Moraki, Pagona Flevari, Maria Dimopoulou, Vasiliki Bartzi, Hisham Daadaa, Georges El Hasbani, Suzanne Koussa, Federica Ammendola, Saverio Scianguetta, Marta Puglia, Ilaria Ferrara, Giovanni Ferrero, Carmen Gaglioti, Filomena Longo, Silvia Turrini, Vincenzo Voi, Elena Cassinerio, Anna De, Giovanna Graziadei, Alessia Marcon, Margherita Migone De Amicis, Irene Motta, Patrizia Cinque, Bruno Pannone, Paolo Ricchi, Manuela Balocco, Paola Carrara, Francesco Della Rovere, Martina Lamagna, Valeria Pinto, Sabrina Quintino, Perla Eleftheriou, Maciej Garbowski, Arne de Kreuk, Susan Carson, Christopher Denton, Tom Hofstra, Sayany Veluswamy, John Wood, Sherif Badawy, Rachel Bercovitz, Rukhmi Bhat, Diane Calamaras, Robert Liem, Astrid Mack
Background In patients with non-transfusion-dependent beta-thalassaemia, haemoglobin concentrations lower than 10 g/dL are associated with a higher risk of morbidity, mortality, and impaired quality of life. No drugs are specifically approved for ana
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ee0b05dfe2f212574c84ccff10e5f0f
https://hdl.handle.net/11591/497789
https://hdl.handle.net/11591/497789
Autor:
Rami S, Komrokji, Uwe, Platzbecker, Pierre, Fenaux, Amer M, Zeidan, Guillermo, Garcia-Manero, Ghulam J, Mufti, Valeria, Santini, María, Díez-Campelo, Carlo, Finelli, Joseph G, Jurcic, Peter L, Greenberg, Mikkael A, Sekeres, Amy E, DeZern, Michael R, Savona, Jeevan K, Shetty, Rodrigo, Ito, George, Zhang, Xianwei, Ha, Jay T, Backstrom, Amit, Verma
Publikováno v:
Leukemia. 36(5)
Publikováno v:
Blood. 106:2517-2517
Previous CALGB trials published by Silverman et al (JCO2002;20:2429) have shown azacitidine to be efficacious and well tolerated in the treatment of MDS at a dosing schedule of 75 mg/m2/day x 7 days every 28 days. The objective of this phase II, mult